Search
for
Sort by
Research 451–480 of 1000+
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system
- Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- Endocrine evaluation of hirsutism
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Hirsutism: A Clinico-investigative Study
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China
- A comparative study of cutaneous manifestations of hyperandrogenism in obese and non-obese Taiwanese women
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Effect of a low-starch/low-dairy diet on fat oxidation in overweight and obese women with polycystic ovary syndrome
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Common urologic diseases in older men and their treatment: how they impact fertility
- Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Pattern of Hyperandrogenemia in Patients with Polycystic Ovary Syndrome at a Tertiary Care Hospital
- Association Between Insulin Resistance and Hyperandrogenism in Women with PCOS. A Cross-Sectional Clinical Study
- Nutritional Assessment of Selected Emerging Adult Women with Poly Cystic Ovarian Syndrome
- Corrigendum: Hair and Salivary Testosterone, Hair Cortisol, and Externalizing Behaviors in Adolescents